Nisa Investment Advisors
BNTC icon

Nisa Investment Advisors’s Benitec Biopharma BNTC Stock Holding History

Nisa Investment Advisors’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Buy
+2,900
New +$34.4K ﹤0.01% 1954

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Nisa Investment Advisors's BNTC Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Benitec Biopharma (BNTC) in Q2 2026: 2,900 shares worth $38.8K. The stake represents ﹤0.01% of the portfolio and ranks #1954 among its holdings.

87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Nisa Investment Advisors held 2,900 shares of Benitec Biopharma worth $38.8K as of Q2 2026.
  • Benitec Biopharma was a new Nisa Investment Advisors position in Q2 2026.
  • Benitec Biopharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1954 holding.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.